4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-065068
EVP, Research & CSO sold 3,805 shares at $31.19 ($118,683)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-12-22 | Option exercise | +3,805 | $1.53 | $5,822 | 27,505 | D |
| Virgin Herbert EVP, Research & CSO | 2020-12-22 | Sale | −3,805 | $31.19 | $118,683 | 23,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-12-22 | Option exercise · Stock Option (Right to Buy) | −3,805 | 435,290 | D | ||
| Open-market sales · 3,805 sh · avg $31.19 · $118,683 | |||||||
Loading xslF345X03/doc4.xml…